MX2013001450A - Composicion farmaceutica y metodo para inhibir la produccion o amplificar la eliminacion de la proteina p24. - Google Patents
Composicion farmaceutica y metodo para inhibir la produccion o amplificar la eliminacion de la proteina p24.Info
- Publication number
- MX2013001450A MX2013001450A MX2013001450A MX2013001450A MX2013001450A MX 2013001450 A MX2013001450 A MX 2013001450A MX 2013001450 A MX2013001450 A MX 2013001450A MX 2013001450 A MX2013001450 A MX 2013001450A MX 2013001450 A MX2013001450 A MX 2013001450A
- Authority
- MX
- Mexico
- Prior art keywords
- leu
- receptor
- lys
- activated
- gln
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010133046/15A RU2517084C2 (ru) | 2010-08-06 | 2010-08-06 | Способ и средство для ингибирования продукции или усиления элиминации белка р24 |
| PCT/IB2011/002355 WO2012017322A2 (en) | 2010-08-06 | 2011-07-15 | Pharmaceutical composition and method of inhibiting of production or amplifying elimination of p24 protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2013001450A true MX2013001450A (es) | 2013-10-25 |
Family
ID=44899160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013001450A MX2013001450A (es) | 2010-08-06 | 2011-07-15 | Composicion farmaceutica y metodo para inhibir la produccion o amplificar la eliminacion de la proteina p24. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20120263726A1 (https=) |
| JP (1) | JP2013535483A (https=) |
| CN (1) | CN103179987A (https=) |
| AU (1) | AU2011287286A1 (https=) |
| CA (1) | CA2807523A1 (https=) |
| DE (1) | DE112011102639T5 (https=) |
| EA (1) | EA029791B1 (https=) |
| ES (1) | ES2415029R1 (https=) |
| GB (1) | GB2496356A (https=) |
| IT (1) | ITTO20110636A1 (https=) |
| MX (1) | MX2013001450A (https=) |
| PH (1) | PH12013500233A1 (https=) |
| RU (1) | RU2517084C2 (https=) |
| SG (1) | SG187735A1 (https=) |
| UA (1) | UA112752C2 (https=) |
| WO (1) | WO2012017322A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
| EA029436B1 (ru) | 2010-07-15 | 2018-03-30 | Олег Ильич ЭПШТЕЙН | Комбинированная фармацевтическая композиция для лечения рассеянного склероза и инфекционных заболеваний, сопровождающихся нейротоксическими нарушениями, и способы лечения указанных заболеваний |
| FR2962656A1 (fr) | 2010-07-15 | 2012-01-20 | Oleg Iliich Epshtein | Procede pour augmenter l'effet d'une forme activee-potentialisee d'un anticorps |
| EP2596019A2 (en) | 2010-07-21 | 2013-05-29 | Oleg Iliich Epshtein | A method of treating attention deficit hyperactivity disorder |
| RU2013111961A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| RU2013111962A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| RU2603623C2 (ru) * | 2014-06-06 | 2016-11-27 | Олег Ильич Эпштейн | Ветеринарная композиция и способ улучшения жизнеспособности животных, стимуляции прироста живой массы млекопитающих и птиц, повышения эффективности иммунизации, профилактики и/или лечения инфекционных заболеваний (варианты) |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311897A (en) | 1979-08-28 | 1982-01-19 | Union Carbide Corporation | Plasma arc torch and nozzle assembly |
| DE4236069A1 (de) * | 1992-10-26 | 1994-04-28 | Werner Dr Bergmann | Arzneimittel, insbesondere für orale Einnahme |
| US5567604A (en) * | 1993-04-23 | 1996-10-22 | Aronex Pharmaceuticals, Inc. | Anti-viral guanosine-rich oligonucleotides |
| CN1327896C (zh) * | 1996-10-10 | 2007-07-25 | 探针国际公司 | 治疗病毒感染的组合物及方法 |
| WO2001016182A2 (en) * | 1999-08-27 | 2001-03-08 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | POLYPEPTIDES THAT BIND HIV gp120 AND RELATED NUCLEIC ACIDS, ANTIBODIES, COMPOSITIONS, AND METHODS OF USE |
| AU2265701A (en) * | 1999-12-16 | 2001-06-25 | Tanox, Inc. | Anti-hiv-1 conjugates for treatment of hiv disease |
| RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2001134982A (ru) * | 2001-12-26 | 2004-02-20 | Олег Ильич Эпштейн | Способ коррекции иммунного ответа и лекарственное средство |
| CN1620307A (zh) * | 2002-06-28 | 2005-05-25 | 扶桑药品工业株式会社 | 抗hiv剂 |
| UA76641C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози |
| UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
| EP1543166A4 (en) * | 2002-09-27 | 2009-10-28 | Genentech Inc | SYNERGETIC COMPOSITIONS FOR PREVENTING AND TREATING THE ACQUIRED IMMUNE WEAKNESS SYNDROME |
| US7229648B2 (en) | 2003-03-14 | 2007-06-12 | Dreyer Lee R | Homeopathic formulations useful for treating pain and/or inflammation |
| RU2393873C2 (ru) * | 2005-05-02 | 2010-07-10 | Майметикс Корпорейшн | Антитело или его фрагмент, имеющие нейтрализующую активность в отношении вич, но не в отношении il2 |
| RU2315058C1 (ru) * | 2006-09-27 | 2008-01-20 | Институт органической химии Уфимского научного центра РАН | Гликопептид глицирризиновой кислоты с глицил-l-фенилаланином, проявляющий анти-вич-1 активность |
| US20120263725A1 (en) * | 2010-08-06 | 2012-10-18 | Epshtein Oleg Iiiich | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV |
-
2010
- 2010-08-06 RU RU2010133046/15A patent/RU2517084C2/ru not_active IP Right Cessation
-
2011
- 2011-07-15 SG SG2013009022A patent/SG187735A1/en unknown
- 2011-07-15 CN CN2011800388401A patent/CN103179987A/zh active Pending
- 2011-07-15 US US13/135,897 patent/US20120263726A1/en not_active Abandoned
- 2011-07-15 GB GB1303865.8A patent/GB2496356A/en not_active Withdrawn
- 2011-07-15 JP JP2013522317A patent/JP2013535483A/ja active Pending
- 2011-07-15 UA UAA201300111A patent/UA112752C2/uk unknown
- 2011-07-15 AU AU2011287286A patent/AU2011287286A1/en not_active Abandoned
- 2011-07-15 MX MX2013001450A patent/MX2013001450A/es unknown
- 2011-07-15 ES ES201390020A patent/ES2415029R1/es active Pending
- 2011-07-15 WO PCT/IB2011/002355 patent/WO2012017322A2/en not_active Ceased
- 2011-07-15 IT IT000636A patent/ITTO20110636A1/it unknown
- 2011-07-15 DE DE112011102639T patent/DE112011102639T5/de not_active Withdrawn
- 2011-07-15 EA EA201300138A patent/EA029791B1/ru not_active IP Right Cessation
- 2011-07-15 CA CA2807523A patent/CA2807523A1/en not_active Abandoned
- 2011-07-15 PH PH1/2013/500233A patent/PH12013500233A1/en unknown
-
2013
- 2013-05-15 US US13/894,476 patent/US20130315964A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2415029R1 (es) | 2013-09-17 |
| DE112011102639T5 (de) | 2013-10-02 |
| AU2011287286A1 (en) | 2013-03-14 |
| PH12013500233A1 (en) | 2017-08-23 |
| GB2496356A (en) | 2013-05-08 |
| CA2807523A1 (en) | 2012-02-09 |
| RU2010133046A (ru) | 2012-02-20 |
| SG187735A1 (en) | 2013-03-28 |
| ITTO20110636A1 (it) | 2012-02-07 |
| EA201300138A1 (ru) | 2014-03-31 |
| WO2012017322A2 (en) | 2012-02-09 |
| GB201303865D0 (en) | 2013-04-17 |
| ES2415029A2 (es) | 2013-07-23 |
| US20130315964A1 (en) | 2013-11-28 |
| WO2012017322A3 (en) | 2012-04-19 |
| CN103179987A (zh) | 2013-06-26 |
| EA029791B1 (ru) | 2018-05-31 |
| RU2517084C2 (ru) | 2014-05-27 |
| UA112752C2 (uk) | 2016-10-25 |
| ES2415029A8 (es) | 2013-09-16 |
| US20120263726A1 (en) | 2012-10-18 |
| JP2013535483A (ja) | 2013-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20120294899A1 (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV | |
| MX2013001451A (es) | Composicion farmaceutica combinada y metodos para el tratamiento y prevencion de las enfermedades infecciosas. | |
| MX2013001450A (es) | Composicion farmaceutica y metodo para inhibir la produccion o amplificar la eliminacion de la proteina p24. | |
| US20120263725A1 (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV | |
| RU2535033C2 (ru) | Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида | |
| SG187034A1 (en) | A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system | |
| RU2517085C2 (ru) | Комплексное лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида | |
| WO2012017327A2 (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv | |
| RU2523451C2 (ru) | Способ лечения хронической сердечной недостаточности и фармацевтическая композиция для лечения хронической сердечной недостаточности | |
| RU2441023C1 (ru) | Лекарственное средство для лечения рассеянного склероза и способ лечения рассеянного склероза | |
| CA2807529A1 (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases |